Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Style
News
Style
News
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
About – Contact
Institutional Investors
Analysts
Side Stories
Disclaimer
Search
Search
Login
HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2023 PSYCHEDELIC INVESTOR CONFERENCE
SEARCH BY SYMBOL
Home
Search
Search
Category:
RESEARCH
INTERVIEW
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
Editor | Curator
-
June 4, 2023
Uncategorized
Psychedelic Marketing: Adrian Morrison
Editor | Curator
-
May 24, 2023
2023 Watch List
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
Editor | Curator
-
May 15, 2023
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
PSYCH STOCK NEWS
Editor | Curator
-
October 2, 2021
Psychedelic Stock Review Initiates Coverage on Ehave Inc. MIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics...
View Post
Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company
RESEARCH
Editor | Curator
-
September 24, 2021
WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First what it isn’t. In early August our research team...
View Post
Subscribe for Free!
RESEARCH
Editor | Curator
-
August 9, 2021
EXCELLENT CHOICE, SIR! AND CHEERS TO YOU FOR SUBSCRIBING Subscribe For Your Free Copy to the 2021 Psychedelic Investor Guide
View Post
Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.
RESEARCH
Editor | Curator
-
July 27, 2021
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT
View Post
Most Popular
Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.
INTERVIEW
Editor | Curator
-
June 4, 2023
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
Psychedelic Marketing: Adrian Morrison
Uncategorized
Editor | Curator
-
May 24, 2023
https://youtu.be/EZPAoTFqaro
Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes
2023 Watch List
Editor | Curator
-
May 15, 2023
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.